Seven early-career scientists are joining the ranks of
Boettcher Investigators in the Webb-Waring Biomedical Research Program, with today’s announcement from Theodore F. Schlegel, M.D., Chairman of the Boettcher Foundation Board of Trustees.
“The Boettcher Foundation Board is pleased to celebrate our fifth class in this very specialized and important niche of biomedical research,” Schlegel said. “Our investigators now number 29, and several of our early Investigators are already achieving significant advancements in their areas of research.”
The 2014 Class of Boettcher Investigators in the Webb-Waring Biomedical Research Program includes:
* Kunhua Song, PhD, University of Colorado Anschutz Medical Campus, Assistant Professor of Medicine - Regenerative medicine and heart development/disease
* Roger A. Bannister, PhD, University of Colorado Anschutz Medical Campus, Assistant Professor of Medicine, Cardiology Division - Skeletal and cardiac muscle physiology
* Subhajyoti De, PhD, University of Colorado Anschutz Medical Campus, Assistant Professor of Biomedical Informatics and Personalized Medicine - Cancer genomics; lung cancer; somatic mutations; DNA damage and repair; algorithm development; optimization
* Loren Hough, PhD, University of Colorado Boulder, Assistant Professor of Physics - Structural biology of order and disordered proteins
* Christopher L. Gentile, PhD, Colorado State University, Assistant Professor of Food Science and Human Nutrition - Molecular causes of vascular dysfunction
* Amy B. Dounay, PhD, Colorado College, Assistant Professor of Chemistry and Biochemistry - Medicinal chemistry for African Sleeping Sickness
* Rachel L. Zemans, MD, National Jewish Hospital, Assistant Professor of Medicine - Resolution of Alveolar Epithelial Permeability after Lung Injury
“The new class of Boettcher Investigators represents some of the finest scientific minds in the state, and we are honored to have the opportunity to support their research, which has the potential to have significant impacts on human health,” said Tim Schultz, President and Executive Director of the Boettcher Foundation.
Boettcher Investigators are awarded grants of $225,000, covering up to three years of research with a goal for these early-career scientists to establish themselves and become competitive for major awards from federal agencies and private foundations. With the addition of the 2014 Class, there are now 29 Boettcher Investigators conducting research in the following Colorado institutions: University of Colorado Anschutz Medical Campus, University of Colorado Boulder, Colorado State University, National Jewish Health, Colorado School of Mines and Colorado College.
The Webb-Waring Biomedical Research Program was created in 2008, as the result of an innovative agreement among the Boettcher Foundation, the Webb-Waring Foundation for Biomedical Research and the University of Colorado. Through the program, the Boettcher Foundation now invests more than $1.5 million each year into efforts to increase Colorado's competitiveness in biomedical science.
Link to the full release
Link to the related Business Wire release
.JPG)
.jpg){kind=logo}
.png)
.JPG)
